IL2 and graft versus host disease: Collectively, these data suggest that L72-FSY and its long-acting form are superior to WT-IL-2, can selectively induce Tregs in pristane-induced lupus mice, and are more effective in mitigating inflammatory diseases such as SLE and GvHD.